A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States (vol 21, pg 835, 2018)

被引：0
作者：
Nuijten, M. [1 ]
Marczewska, A. [1 ]
Torres, Araujo K. [1 ]
Rasouli, B. [1 ]
Perugini, M. [1 ]
机构：
[1] Ars Accessus Med, Amsterdam, Netherlands
来源：
JOURNAL OF MEDICAL ECONOMICS | 2018年 / 21卷 / 09期
关键词：
D O I：
10.1080/13696998.2018.1484647
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：845 / 845
页数：1
相关论文
共 50 条
  • [21] THE COST-EFFECTIVENESS OF PREGABALIN (LYRICA®) IN THE TREATMENT OF SEVERE FIBROMYALGIA IN THE UNITED STATES
    Lloyd, A.
    Castelnuovo, E.
    Boomershine, C. S.
    Choy, E.
    Chandran, A.
    Zlateva, G.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A126 - A126
  • [22] Short-term cost-effectiveness of tirzepatide for the treatment of type 2 diabetes in the United States (vol 29, pg 276, 2023)
    Zhang, Z.
    Marx, C. McAdam
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (06) : 714 - 714
  • [23] The Cost-Effectiveness of Bortezomib for the Initial Treatment of Multiple Myeloma in the United States
    Wang, Si-Tien
    Huang, Hui
    Shi, Hongliang
    Duh, Mei Sheng
    Chen, Ktistina
    Chang, Eva
    Korves, Caroline
    Dhawan, Ravinder
    Cakana, Andrew
    van de Velde, Helgi
    Esseltine, Dixie-Lee
    Garrison, Louis
    [J]. BLOOD, 2009, 114 (22) : 561 - 562
  • [24] EVALUATING THE COST-EFFECTIVENESS OF VOCLOSPORIN IN THE UNITED STATES FOR THE TREATMENT OF LUPUS NEPHRITIS
    Flauto, Ronald
    Lee, Ernie
    Atencio, Victoria
    Birardi, Vanessa
    Kennedy, Lisa
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S113 - S113
  • [25] Modelling the cost-effectiveness of tofacitinib for the treatment of rheumatoid arthritis in the United States
    Claxton, Lindsay
    Taylor, Matthew
    Gerber, Robert A.
    Gruben, David
    Moynagh, Dermot
    Singh, Amitabh
    Wallenstein, Gene, V
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (11) : 1991 - 2000
  • [26] Evaluating the cost-effectiveness of voclosporin for the treatment of lupus nephritis in the United States
    Kennedy, Lisa
    Lee, Ernie
    Flauto, Ronald
    Atencio, Victoria
    Birardi, Vanessa
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (08) : 773 - 781
  • [27] Cost-effectiveness analysis of tissue plasminogen activator in acute ischemic stroke in Iran (vol 21, pg 282, 2018)
    Amiri, A.
    Goudarzi, R.
    Amiresmaili, M.
    Iranmanesh, F.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (03) : 312 - 312
  • [28] External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions
    Sandra Lopes
    Pierre Johansen
    Mark Lamotte
    Phil McEwan
    Anamaria-Vera Olivieri
    Volker Foos
    [J]. PharmacoEconomics, 2020, 38 : 1123 - 1133
  • [29] External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions
    Lopes, Sandra
    Johansen, Pierre
    Lamotte, Mark
    McEwan, Phil
    Olivieri, Anamaria-Vera
    Foos, Volker
    [J]. PHARMACOECONOMICS, 2020, 38 (10) : 1123 - 1133
  • [30] Designing and testing of a health-economic Markov model to assess the cost-effectiveness of treatments for Bipolar disorder: TiBipoMod
    Kleijburg, Anne
    Lokkerbol, Joran
    Regeer, Eline J.
    Geerling, Bart
    Evers, Silvia M. A. A.
    Kroon, Hans
    Wijnen, Ben
    [J]. FRONTIERS IN PSYCHIATRY, 2022, 13
12345